Methods for altering insulin secretion

Details for Australian Patent Application No. 2005218724 (hide)

Owner Merck Patent GmbH

Inventors Lang, Florian

Agent Davies Collison Cave

Pub. Number AU-A-2005218724

PCT Pub. Number WO2005/084651

Priority 04005404.1 08.03.04 EP

Filing date 10 February 2005

Wipo publication date 15 September 2005

International Classifications

A61K 31/15 (2006.01) - Oximes (CNO)

A61K 31/16 (2006.01) - Amides, e.g. hydroxamic acids

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

Event Publications

26 October 2006 PCT application entered the National Phase

  PCT publication WO2005/084651 Priority application(s): WO2005/084651

2 September 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005218729-New therapeutic use for a group of sulphated polysaccharides

2005218713-Crystalline composition containing escitalopram oxalate